Skip to content
From Pop-Up Coffee Shop to Downtown Storefront, 321 Coffee Continues to Grow
Park alumni-owned 321 Coffee continues to grow, preparing to launch a storefront in downtown Raleigh this spring.
Startup Stories: 321 Coffee
Lewis Sheats, assistant vice provost of entrepreneurship, sits down with the founders of 321 Coffee, Lindsay Wrege '21 and Michael Evans '21, to discuss how to provide employees with disabilities a meaningful way to contribute to society.
Brewing Connections: Park Alumni Help 321 Coffee Thrive
The Park Scholars leading 321 Coffee have used Park alumni connections to take their business to the next level.
Guiding Young Businesses to Success
With experiential learning programs and funding opportunities, NC State Entrepreneurship has helped Shraddha Rathod '18 and Ritika Shamdasani '23 turn their ideas into reality.
Taking Care of Business
Agile Park entrepreneurs lead their companies through the COVID-19 pandemic.
Character, Service, and Leadership Deemed Essential as Park Alumni Care for Their Communities
Physicians Tracy Forrest '04 and Lauren Gainor '04 share their experiences treating North Carolinians during the pandemic.
Musical Arrangement: Mary Beth Martin ’08 Helps Expose North Carolina’s Musical Roots
As executive director of the Earl Scruggs Center, Mary Beth Martin '08 heads efforts to celebrate the legacy of a bluegrass and country music legend.
Entrepreneurs Flexing with the Times
Emily Neville '20 is not letting a global pandemic stop the growth of her textiles company, Reborn Clothing Co. In fact, they are hiring.
Emily Holmes ’07 Co-Leads Program to Support Health Care Workers Responding to COVID-19
Dr. Emily Holmes ’07 co-leads IU Health's Stress, Trauma, and Grief Engagement Supports (STAGES) Program, a key part of the hospital's COVID-19 response.
Alum on Front Line of Pandemic: ‘Stay Home’
Chris Arbonies '07, a New Orleans physician and Park Scholar, returned to work after recovering from COVID-19. He urges others to follow CDC guidelines for reducing the spread of the novel coronavirus.